1. Home
  2. MNPR vs WRAP Comparison

MNPR vs WRAP Comparison

Compare MNPR & WRAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNPR
  • WRAP
  • Stock Information
  • Founded
  • MNPR 2014
  • WRAP 2016
  • Country
  • MNPR United States
  • WRAP United States
  • Employees
  • MNPR N/A
  • WRAP N/A
  • Industry
  • MNPR Biotechnology: Pharmaceutical Preparations
  • WRAP Ordnance And Accessories
  • Sector
  • MNPR Health Care
  • WRAP Industrials
  • Exchange
  • MNPR Nasdaq
  • WRAP Nasdaq
  • Market Cap
  • MNPR 113.5M
  • WRAP 91.2M
  • IPO Year
  • MNPR 2019
  • WRAP N/A
  • Fundamental
  • Price
  • MNPR $28.54
  • WRAP $2.06
  • Analyst Decision
  • MNPR Strong Buy
  • WRAP
  • Analyst Count
  • MNPR 4
  • WRAP 0
  • Target Price
  • MNPR $38.50
  • WRAP N/A
  • AVG Volume (30 Days)
  • MNPR 59.4K
  • WRAP 313.3K
  • Earning Date
  • MNPR 11-08-2024
  • WRAP 11-14-2024
  • Dividend Yield
  • MNPR N/A
  • WRAP N/A
  • EPS Growth
  • MNPR N/A
  • WRAP N/A
  • EPS
  • MNPR N/A
  • WRAP N/A
  • Revenue
  • MNPR N/A
  • WRAP $4,231,000.00
  • Revenue This Year
  • MNPR N/A
  • WRAP N/A
  • Revenue Next Year
  • MNPR N/A
  • WRAP N/A
  • P/E Ratio
  • MNPR N/A
  • WRAP N/A
  • Revenue Growth
  • MNPR N/A
  • WRAP N/A
  • 52 Week Low
  • MNPR $1.55
  • WRAP $1.21
  • 52 Week High
  • MNPR $38.50
  • WRAP $7.01
  • Technical
  • Relative Strength Index (RSI)
  • MNPR 60.16
  • WRAP 58.73
  • Support Level
  • MNPR $24.00
  • WRAP $1.95
  • Resistance Level
  • MNPR $26.52
  • WRAP $2.14
  • Average True Range (ATR)
  • MNPR 2.42
  • WRAP 0.19
  • MACD
  • MNPR 0.32
  • WRAP -0.00
  • Stochastic Oscillator
  • MNPR 68.85
  • WRAP 67.24

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

Share on Social Networks: